Safety Study of GE-145 320 mg I/mL Injection vs. Iopamidol 370 mg I/mL in Elderly Subjects Undergoing Coronary Procedure
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 284 participants.
Also called NCT01252810
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose diagnostic
- Phase
- Phase 2
- Enrolled
- 284 participants
- Sponsor
- Registry
-
NCT01252810
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT01252810. Randomized; double masking; primary purpose diagnostic. Start 2010-11 (registry gives no type); primary completion 2012-12 (actual). Results posted on 2014-05-02.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety Study of GE-145 320 mg I/mL Injection vs. Iopamidol 370 mg I/mL in Elderly Subjects Undergoing Coronary Procedure
- Condition
- Chronic Renal Insufficiency
- Condition
- Diabete Mellitus
- Condition
- Congestive Heart Failure
- Intervention (Drug)
- GE-145
- Lead sponsor
- GE Healthcare
- Collaborator
- i3 Statprobe
- Collaborator
- Medpace, Inc.
- Collaborator
- Biomedical Systems
- Collaborator
- Rules-Based Medicine, Inc.
Record details
- Record id
cardio:ct-nct01252810- Content hash
f48bfd7e3db3e335a6c41bdb69202baf8a14bca6e3e5667e254eb115901c67b8